hexadecanesulfonyl fluoride has been researched along with anandamide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chavatte, P; Leleu-Chavain, N; Millet, R; Sansook, S; Spencer, J; Tuo, W | 1 |
| Arreaza, G; Deutsch, DG; Hill, WA; Lin, S; Makriyannis, A; Morse, KL; Omeir, RL; Salehani, D | 1 |
| Bruneus, M; Gatley, SJ; Gifford, AN; Goutopoulos, A; Lin, S; Makriyannis, A; Volkow, ND | 1 |
| Rice, AS | 1 |
| Aberman, JE; Arizzi, MN; Betz, A; Cervone, KM; Lin, S; Liu, Q; Makriyannis, A; Salamone, JD | 1 |
| Bahr, BA; Karanian, DA; Karim, SL; Lin, S; Makriyannis, A; Williams, JS; Wood, JT | 1 |
2 review(s) available for hexadecanesulfonyl fluoride and anandamide
| Article | Year |
|---|---|
Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.
Topics: Amidohydrolases; Animals; Enzyme Inhibitors; Humans; Monoacylglycerol Lipases | 2017 |
Cannabinoids and pain.
Topics: Amides; Amidohydrolases; Analgesics; Animals; Arachidonic Acids; Benzoxazines; Brain; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Cell Membrane; Clinical Trials as Topic; Disease Models, Animal; Drug Design; Drug Interactions; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Glycerides; Humans; Injections, Spinal; Molecular Structure; Morpholines; Naphthalenes; Pain; Palmitates; Palmitic Acids; Piperidines; Plant Extracts; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Spinal Cord | 2001 |
4 other study(ies) available for hexadecanesulfonyl fluoride and anandamide
| Article | Year |
|---|---|
Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Brain; Cannabinoids; Endocannabinoids; Enzyme Inhibitors; Fatty Acids; Neurons; Palmitates; Phenylmethylsulfonyl Fluoride; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship; Sulfones; Tumor Cells, Cultured | 1997 |
Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374).
Topics: Acetylcholine; Amidohydrolases; Animals; Arachidonic Acids; Benzoxazines; Cannabinoids; Cyclohexanols; Drug Synergism; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Hippocampus; In Vitro Techniques; Male; Morpholines; Naphthalenes; Palmitates; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug | 1999 |
Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Behavior, Animal; Cannabinoids; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Synergism; Endocannabinoids; Enzyme Inhibitors; Injections, Intraperitoneal; Injections, Intraventricular; Male; Palmitates; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Reinforcement Schedule | 2004 |
Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Endocannabinoids; Hippocampus; Kainic Acid; MAP Kinase Signaling System; Neuroprotective Agents; Palmitates; Polyunsaturated Alkamides; Rats; Seizures | 2007 |